Skip to main content

Table 1 Patient characteristics

From: Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia

Variables Number (%) or Median (mean±SD)
No. of patients 19
Age, years 72.0 (72.1 ± 10.6)
Prostate vol, mL 37.3 (41.9 ± 25.3)
Serum PSA, ng/mL 3.6 (4.7 ± 4.1)
Uroflowmetry  
Peak flow rate, mL/s 10.5 (13.2 ± 10.0)
Average flow rate, mL/s 5.0 (7.1 ± 5.5)
Residual volume, mL 20.0 (20 ± 21.8)
Type of alpha-1-adrenergic antagonists (blockers)  
Tamsulosin (0.2 mg/day) 8 (42.1%)
Silodosin (8 mg/day) 2 (10.5%)
Naftopidil (75 mg/day) 9 (47.4%)